Literature DB >> 9130657

Epitope cleavage by Leishmania endopeptidase(s) limits the efficiency of the exogenous pathway of major histocompatibility complex class I-associated antigen presentation.

M R Garcia1, S Graham, R A Harris, S M Beverley, P M Kaye.   

Abstract

The activation of CD8+ T cell responses is commonplace during infection with a number of nonviral pathogens. Consequently, there has been much interest in the pathways of presentation of such exogenous antigens for major histocompatibility complex class I-restricted recognition. We had previously shown that Leishmania promastigotes transfected with the ovalbumin (OVA) gene could efficiently target OVA to the parasitophorous vacuole (PV), with subsequent recognition by class II-restricted T cells. We now report the results of studies aimed at evaluating the PV as a route of entry into the exogenous class I pathway. Bone marrow-derived macrophages can present soluble OVA (albeit at high concentrations) to the OVA(257-264)-specific T cell hybridoma 13.13. In contrast, infection with OVA-transfected Leishmania promastigotes failed to result in the stimulation of this hybridoma. This appeared unrelated to variables such as antigen concentration, parasite survival, and macrophage activation status. These results prompted an analysis of the effects of promastigotes on class I peptide binding using RMA-S cells and OVA(257-264). Our data indicate that the major surface protease of Leishmania, gp63, inhibits this interaction by virtue of its endopeptidase activity against the OVA(257-264) peptide. The data suggest that this activity, if maintained within the PV, would result in loss of the OVA(257-264) epitope. Although we can therefore draw no conclusions from these studies regarding the efficiency of the PV as a site of entry of antigen into the exogenous class I pathway, we have identified a further means by which parasites may manipulate the immune repertoire of their host.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130657     DOI: 10.1002/eji.1830270430

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors.

Authors:  S Nylén; U Mörtberg; D Kovalenko; I Satti; K Engström; M Bakhiet; H Akuffo
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.

Authors:  Sylvie Bertholet; Alain Debrabant; Farhat Afrin; Elisabeth Caler; Susana Mendez; Khaled S Tabbara; Yasmine Belkaid; David L Sacks
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  VAMP3 and VAMP8 Regulate the Development and Functionality of Parasitophorous Vacuoles Housing Leishmania amazonensis.

Authors:  Olivier Séguin; Linh Thuy Mai; Hamlet Acevedo Ospina; Marie-Michèle Guay-Vincent; Sidney W Whiteheart; Simona Stäger; Albert Descoteaux
Journal:  Infect Immun       Date:  2022-02-07       Impact factor: 3.609

Review 4.  Major surface protease of trypanosomatids: one size fits all?

Authors:  Chaoqun Yao
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

5.  Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice.

Authors:  M Huber; E Timms; T W Mak; M Röllinghoff; M Lohoff
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

6.  Synthetic Peptides as Potential Antigens for Cutaneous Leishmaniosis Diagnosis.

Authors:  Juliana Seger Link; Silvana Maria Alban; Carlos Ricardo Soccol; Gilberto Vinicius Melo Pereira; Vanete Thomaz Soccol
Journal:  J Immunol Res       Date:  2017-03-07       Impact factor: 4.818

Review 7.  Transgenic Leishmania and the immune response to infection.

Authors:  L Beattie; K J Evans; P M Kaye; D F Smith
Journal:  Parasite Immunol       Date:  2008-02-04       Impact factor: 2.280

8.  CD8(+) T cells in leishmania infections: friends or foes?

Authors:  Simona Stäger; Sima Rafati
Journal:  Front Immunol       Date:  2012-01-24       Impact factor: 7.561

Review 9.  Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

Authors:  Simona Stäger; Trupti Joshi; Rashmi Bankoti
Journal:  Immunol Res       Date:  2010-07       Impact factor: 4.505

10.  Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.

Authors:  Wafa Markikou-Ouni; Sima Drini; Narges Bahi-Jaber; Mehdi Chenik; Amel Meddeb-Garnaoui
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.